Proimaging

PROIMAGING develops fluorescent labeling dyes for scientific research and medical imaging. Our core business is to bring to the clinical market innovative molecules that allow imaging tumors sometimes difficult to explore or excise surgically. The objective is to provide a complementary medical service useful for imaging cancers per-operative. At the same time, PROIMAGING develops highly effective dyes for scientific research, particularly for cellular imaging. Our products are photostable, non-cytotoxic, and suitable for long-time imaging on living cells. Some of our molecules are compatible with advanced FLIM and STED imaging techniques. We cover a very broad spectrum that includes visible, near-infrared (NIR), and shortwave infrared (SWIR).